Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.

NCT03248427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ribociclib
DRUG: Letrozole 2.5mg
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel

Sponsor

SOLTI Breast Cancer Research Group

Collaborators

[object Object]